• CLSI M02-A12, M07-A10, M100-S27 Package

CLSI M02-A12, M07-A10, M100-S27 Package

Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard -Twelfth Edition / Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard -Tenth Edition / Performance Standards for Antimicrobial Susceptibility Testing,

Clinical and Laboratory Standards Institute, 01/01/2017

Publisher: CLSI

File Format: PDF

$250.00$500.00


Published:01/01/2017

File Size:3 files , 13 MB

Note:This product is unavailable in Russia, Belarus

Package of Three Documents

M02-A12: Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Twelfth Edition
This document contains the current Clinical and Laboratory Standards Institute-recommended methods for disk susceptibility testing, criteria for quality control testing, and updated tables for interpretive zone diameters.

M07-A10: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard -Tenth Edition
This document addresses reference methods for the determination of minimal inhibitory concentrations (MICs) of aerobic bacteria by broth macrodilution, broth microdilution, and agar dilution.

M100-S27: Performance Standards for Antimicrobial Susceptibility Testing; Twenty Seventh Informational Supplement
This document provides updated tables for the Clinical and Laboratory Standards Institute (CLSI) antimicrobial susceptibility testing standards M02-A12, M07-A10, and M11-A8.

Clinicians depend heavily on information from the clinical microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results requires that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents.

The tabular information presented here represents the most current information for drug selection, interpretation, and quality control using the procedures standardized in the most current editions of M02, M07, and M11.

More CLSI standard pdf

CLSI H51-A

CLSI H51-A

Assays of von Willebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline, H51-A

$116.00 $233.68

CLSI GP29A

CLSI GP29A

Assessment of Laboratory Tests When Proficiency Testing is Not Available; Approved Guideline, GP29-A

$103.00 $207.62

CLSI C43A

CLSI C43A

Gas Chromatography/Mass Spectrometry (GC/MS) Confirmation of Drugs; Approved Guideline, 43-A

$110.00 $221.61

CLSI C30A2

CLSI C30A2

Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline, C30-A2

$148.00 $297.17